| Doug's Optical Inc | |
| 1541 University Drive So, Fargo, North Dakota 58103 | |
| (701) 235-5185 |
| Name | Doug's Optical Inc |
|---|---|
| Organization Name | Dougs Optical Inc |
| Location | 1541 University Drive So, Fargo, North Dakota 58103 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (701) 235-5185 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Today's headlines include details about today's health law repeal vote in the House. It comes just as lawmakers prepare to leave for the August break.
Rep. Darrell Issa, R-Calif., who chairs the House Oversight and Government Reform Committee, released more than 100 pages of documents showing how the difficulties and glitches were chronicled.
Cellzome today announced that it has formed a second strategic alliance with GlaxoSmithKline (GSK). This new collaboration gives GSK exclusive access to Cellzome's proprietary Episphere(TM) technology in the emerging field of epigenetics as applied to immunoinflammatory disease. Epigenetic mechanisms play a key role in controlling immune cell differentiation and inflammatory gene expression during an excessive inflammatory response.
The US Food and Drugs Administration (FDA) has approved Byetta (exenatide) injection as add-on treatment for use with insulin glargine, together with exercise and diet for diabetes type 2 patients who are not responding well enough to glargine alone. Byetta's add-on therapy is for those on glargine with metformin and/or a TZD (thiazolidinedione) or without.
Increased levels of alexithymia among patients with schizophrenia are associated with reductions in white matter integrity in specific regions of the corpus callosum, researchers report.
› Verified 1 days ago
| NPI Number | 1215351440 |
| Organization Name | DOUG'S OPTICAL, INC |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 1547 University Dr S, Fargo, ND 58103 |
| Phone Number | 701-235-5185 |
News Archive
Today's headlines include details about today's health law repeal vote in the House. It comes just as lawmakers prepare to leave for the August break.
Rep. Darrell Issa, R-Calif., who chairs the House Oversight and Government Reform Committee, released more than 100 pages of documents showing how the difficulties and glitches were chronicled.
Cellzome today announced that it has formed a second strategic alliance with GlaxoSmithKline (GSK). This new collaboration gives GSK exclusive access to Cellzome's proprietary Episphere(TM) technology in the emerging field of epigenetics as applied to immunoinflammatory disease. Epigenetic mechanisms play a key role in controlling immune cell differentiation and inflammatory gene expression during an excessive inflammatory response.
The US Food and Drugs Administration (FDA) has approved Byetta (exenatide) injection as add-on treatment for use with insulin glargine, together with exercise and diet for diabetes type 2 patients who are not responding well enough to glargine alone. Byetta's add-on therapy is for those on glargine with metformin and/or a TZD (thiazolidinedione) or without.
Increased levels of alexithymia among patients with schizophrenia are associated with reductions in white matter integrity in specific regions of the corpus callosum, researchers report.
› Verified 1 days ago
News Archive
Today's headlines include details about today's health law repeal vote in the House. It comes just as lawmakers prepare to leave for the August break.
Rep. Darrell Issa, R-Calif., who chairs the House Oversight and Government Reform Committee, released more than 100 pages of documents showing how the difficulties and glitches were chronicled.
Cellzome today announced that it has formed a second strategic alliance with GlaxoSmithKline (GSK). This new collaboration gives GSK exclusive access to Cellzome's proprietary Episphere(TM) technology in the emerging field of epigenetics as applied to immunoinflammatory disease. Epigenetic mechanisms play a key role in controlling immune cell differentiation and inflammatory gene expression during an excessive inflammatory response.
The US Food and Drugs Administration (FDA) has approved Byetta (exenatide) injection as add-on treatment for use with insulin glargine, together with exercise and diet for diabetes type 2 patients who are not responding well enough to glargine alone. Byetta's add-on therapy is for those on glargine with metformin and/or a TZD (thiazolidinedione) or without.
Increased levels of alexithymia among patients with schizophrenia are associated with reductions in white matter integrity in specific regions of the corpus callosum, researchers report.
› Verified 1 days ago
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1609 32nd Ave S, Fargo, North Dakota 58103 Phone: (701) 235-0175 | |
Partner Medical Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5256 50th Ave S, Fargo, North Dakota 58104 Phone: (701) 356-4813 | |
The Medicine Shoppe Type: Pharmacy Location: 2800 Broadway N, Fargo, North Dakota 58102 Phone: (701) 293-0221 | |
Cvs Pharmacy #08612 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2425 13th Ave S, Fargo, North Dakota 58103 Phone: (701) 232-4872 | |
Cvs Pharmacy #08613 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1321 19th Ave N, Fargo, North Dakota 58102 Phone: (701) 232-2720 |